Lee Cronin
Directeur Général chez Chemify Ltd.
Profil
Lee Cronin is the founder of Chemify Ltd.
which was founded in 2019, where he holds the title of Chief Executive Officer.
Currently, he holds the position of Director at Cronin 3D Ltd.
and the title of Professor at the University of Glasgow.
Mr. Cronin's former position was as Director & Scientific Director at DeepMatter Group Plc from 2015 to 2019.
Postes actifs de Lee Cronin
| Sociétés | Poste | Début |
|---|---|---|
Cronin 3D Ltd.
 Cronin 3D Ltd. Commercial Printing/FormsCommercial Services Cronin 3D Ltd. provides 3D printing services. It develops a platform for the use of nanomaterials in pharmaceuticals through the use of 3D printing. The firm owns and operates a platform which is used in the discovery, optimization, and portable manufacture of small molecules and nanomaterials for the pharmaceutical, formulation, and materials science industries. The company is headquartered in Glasgow, the United Kingdom. | Directeur/Membre du Conseil | - |
| University of Glasgow | Corporate Officer/Principal | - |
Chemify Ltd.
 Chemify Ltd. Chemicals: Major DiversifiedProcess Industries Chemify Ltd. is a company based in Glasgow, UK that leverages chemistry experience, hardware robotics, and artificial intelligence to provide an end-to-end workflow for drug discovery, molecule synthesis, and materials discovery. By digitizing chemistry, Chemify is reimagining chemical research, discovery, and manufacturing to benefit humanity by accelerating advances across chemistry, with a focus on medicine and functional materials. The British company was founded in 2019 by CEO Lee Cronin, who conceptualized advancements from his digital chemistry laboratory at the University of Glasgow. | Directeur Général | 24/10/2019 |
Anciens postes connus de Lee Cronin
| Sociétés | Poste | Fin |
|---|---|---|
| DEEPMATTER GROUP PLC | Directeur Technique/Scientifique/R&D | 12/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Cronin 3D Ltd.
Cronin 3D Ltd. Commercial Printing/FormsCommercial Services Cronin 3D Ltd. provides 3D printing services. It develops a platform for the use of nanomaterials in pharmaceuticals through the use of 3D printing. The firm owns and operates a platform which is used in the discovery, optimization, and portable manufacture of small molecules and nanomaterials for the pharmaceutical, formulation, and materials science industries. The company is headquartered in Glasgow, the United Kingdom. | Commercial Services |
Chemify Ltd.
Chemify Ltd. Chemicals: Major DiversifiedProcess Industries Chemify Ltd. is a company based in Glasgow, UK that leverages chemistry experience, hardware robotics, and artificial intelligence to provide an end-to-end workflow for drug discovery, molecule synthesis, and materials discovery. By digitizing chemistry, Chemify is reimagining chemical research, discovery, and manufacturing to benefit humanity by accelerating advances across chemistry, with a focus on medicine and functional materials. The British company was founded in 2019 by CEO Lee Cronin, who conceptualized advancements from his digital chemistry laboratory at the University of Glasgow. | Process Industries |